Spokane, WA, and Westminster, CO – September 26, 2019 – Gestalt Diagnostics and Flagship Biosciences today announced their collaboration in the development of an integrated workflow for pathologists to access Flagship’s Image Analysis services for digital images to support PD-L1 testing. The companies are providing a more efficient diagnostic process by engaging in a shared service to add Flagship’s computational services to Gestalt’s digital pathology solution, PathFlow™.
Flagship Biosciences appoints Gina Wallar, Ph.D., MPH as new Chief Commercial Officer
Scientist turned business leader will strengthen the company’s commercial operations and bolster business development efforts.BROOMFIELD, CO - March 9, 2023 — Flagship Biosciences, Inc., a leader in spatial biology and biomarker analytics services, announced the...